CeNeS Announces Preliminary Results for the Year Ended December 31, 2002
April 16, 2003 06:58 ET
|
CeNeS Pharmaceuticals Plc
CAMBRIDGE, U.K., April 16, 2003 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) (Other OTC:CPHAF) today announced its results for the year ended 31 December 2002 and an update on its restructuring...
CeNeS Announces Sale of Pharmaceutical Products Raising Total of Over 9m Pounds
April 16, 2003 03:25 ET
|
CeNeS Pharmaceuticals Plc
CAMBRIDGE, U.K., April 16, 2003 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (Other OTC:CPHAF) (LSE:CEN) today announced that it has received and accepted, subject to shareholder approval, an offer from...
CeNeS Announces Phase II Drug Deal With Addex Pharmaceuticals
December 19, 2002 05:15 ET
|
CeNeS Pharmaceuticals Plc
CAMBRIDGE, U.K., Dec. 19, 2002 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) (Other OTC:CPHAF) today announced that it had signed an agreement to partner CEE 03-310, its selective antagonist of...
CeNeS Announces Further Positive Results of its Phase II Clinical Trials of Morphine-6-glucuronide (M6G)
November 15, 2002 03:21 ET
|
CeNeS Pharmaceuticals Plc
CAMBRIDGE, U.K., Nov. 15, 2002 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) (Other OTC:CPHAF) today announced additional positive results from its recent Phase II trial comparing the analgesic...
CeNeS Announces Licensing Deal with Acorda for its Multiple Sclerosis Drug Candidate
November 13, 2002 04:04 ET
|
CeNeS Pharmaceuticals Plc
CAMBRIDGE, U.K., Nov. 13, 2002 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) (Other OTC:CPHAF) today announced that it had signed an agreement to out-licence its recombinant glial growth factor...
CeNeS Reports 2002 Interim Results
September 30, 2002 12:22 ET
|
CeNeS Pharmaceuticals Plc
Cambridge, U.K., Sept. 30, 2002(PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) today announced its unaudited interim financial results for the six months ended 30 June 2002. CeNeS also announced...
CeNeS Pharmaceuticals plc: Interim Results Notification
September 13, 2002 09:25 ET
|
CeNeS Pharmaceuticals Plc
CAMBRIDGE, United Kingdom, Sept. 13, 2002 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) will be announcing its interim results for the six months ended 30 June 2002 on Monday 30th September...
CeNeS Announces Divestment of Its Ion Channel Technology Business
August 15, 2002 04:12 ET
|
CeNeS Pharmaceuticals Plc
CAMBRIDGE, U.K., Aug. 15, 2002 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) today announced the spinout of its ion channel technology development business (Channelwork) as part of the ongoing...
CeNeS Announces Disposal of its Cognitive Testing Division
May 31, 2002 03:39 ET
|
CeNeS Pharmaceuticals Plc
CAMBRIDGE, United Kingdom, May 31, 2002 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) today announced the spin-out of its cognitive testing division as part of the ongoing restructuring...
CeNeS Announces Further Progress in Its Neuropathic Pain Phase II Programme
May 15, 2002 02:31 ET
|
CeNeS Pharmaceuticals Plc
CAMBRIDGE, U.K., May 15, 2002 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) today announced postive interim results from Phase II trials of CNS 5161 for neuropathic pain.
Results from a single...